Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

[1]  R. Califf,et al.  Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction , 1997 .

[2]  E R Bates,et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[3]  R. Califf,et al.  Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial , 1995 .

[4]  K. Lee,et al.  Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, JAMA.

[5]  J Col,et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.

[6]  A. Jacobs,et al.  Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality Results of an International Registry , 1995 .

[7]  R. Califf,et al.  Use of Aortic Counterpulsation to Improve Sustained Coronary Artery Patency During Acute Myocardial Infarction: Results of a Randomized Trial , 1994, Circulation.

[8]  E. Bates,et al.  Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. , 1994, Chest.

[9]  J. Ducas,et al.  Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. , 1994, Journal of the American College of Cardiology.

[10]  P. Gurbel,et al.  Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. , 1994, Circulation.

[11]  R. Califf,et al.  An analysis of the cause of early mortality after administration of thrombolytic therapy , 1993, Coronary artery disease.

[12]  M. Kern,et al.  Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically III patients , 1993 .

[13]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[14]  M. Gotsman,et al.  Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. , 1993, European heart journal.

[15]  R. Califf,et al.  Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. , 1992, Journal of the American College of Cardiology.

[16]  J. Ducas,et al.  Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. , 1992, Journal of the American College of Cardiology.

[17]  B. Chaitman,et al.  Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study. , 1992, Journal of the American College of Cardiology.

[18]  J. Alpert,et al.  Cardiogenic shock after acute myocardial infarction: Incidence and Mortality from a Community-Wide Perspective, 1975 to 1988 , 1991 .

[19]  K. Mann,et al.  Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. , 1991, Annals of internal medicine.

[20]  W. O’Neill,et al.  Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. , 1991, Journal of the American College of Cardiology.

[21]  R. Califf,et al.  The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, American heart journal.

[22]  F. Klocke,et al.  Guidelines for the early management of patients with acute myocardial infarction , 1990 .

[23]  F. Klocke,et al.  ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.

[24]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.

[25]  R. Califf,et al.  Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. , 1988, The American journal of medicine.

[26]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[27]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[28]  J. Weiss,et al.  Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. , 1985, Journal of the American College of Cardiology.

[29]  F. Yin,et al.  Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. , 1983, Circulation.

[30]  H. Gewirtz,et al.  The Effect of Intraaortic Balloon Counterpulsation on Regional M4yocardial Blood Flow and Oxygen Consumption in the Presence of Coronary Artery Stenosis in Patients with Unstable Angina , 1982, Circulation.

[31]  M. O'Rourke,et al.  Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. , 1981, The American journal of cardiology.

[32]  M. Dewood,et al.  Intraaortic Balloon Counterpulsation With and Without Reperfusion for Myocardial Infarction Shock , 1980, Circulation.

[33]  H. Loeb,et al.  Treatment of cardiogenic shock in myocardial infarction by intraaortic balloon counterpulsation surgery. , 1977, The American journal of medicine.

[34]  M. Rubenfire,et al.  Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. , 1973, The New England journal of medicine.